Stockscreener 앱 받기
1.195
1.27%
0.015
시간 외 거래:
1.18
-0.015
-1.26%
전일 마감가:
$1.18
열려 있는:
$1.19
하루 거래량:
149.83K
Relative Volume:
1.53
시가총액:
$3.18M
수익:
$1.31M
순이익/손실:
$-7.56M
주가수익비율:
-0.1161
EPS:
-10.2926
순현금흐름:
$-8.25M
1주 성능:
+6.70%
1개월 성능:
-18.15%
6개월 성능:
-65.95%
1년 성능:
-77.19%
1일 변동 폭
$1.15
$1.26
1주일 범위
$1.10
$1.26
52주 변동 폭
$1.05
$8.62
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
명칭
60 Degrees Pharmaceuticals Inc
전화
202-327-5422
주소
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.195 | 3.00M | 1.31M | -7.56M | -8.25M | -10.29 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
60 Degrees Pharmaceuticals Inc 주식(SXTP)의 최신 뉴스
60 Degrees Pharmaceuticals (NASDAQ: SXTP) files to register 1.77M resale shares from warrant deal - Stock Titan
60 Degrees Q2 revenue jumps 106% to $208K; loss widens - scanx.trade
ARAKODA maker reports about $2.4M Q2 loss with about $208K revenue - Stock Titan
60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results - Yahoo Finance
60 Degrees Pharmaceuticals (SXTP) flags going concern risk as losses deepen - Stock Titan
60 Degrees Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:SXTPW - TradingView
60 Degrees Pharmaceuticals Shareholders Approve Key Governance Actions - The Globe and Mail
60 Degrees Pharmaceuticals Inc (SXTP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
60 Degrees Pharmaceuticals (NASDAQ: SXTP) reports 2026 shareholder vote outcomes - Stock Titan
Lind Global Fund III (SXTP) discloses 5.45% stake with warrant conversion cap - Stock Titan
60 Degrees Pharmaceuticals Completes Private Placement to Raise Capital - TipRanks
60 Degrees Pharmaceuticals Raises $1.0 Million in Private Placement of Stock and Warrants - TradingView
60 Degrees Pharmaceuticals (NASDAQ: SXTP) raises $1M in warrant-backed private placement - Stock Titan
60 Degrees Pharmaceuticals issues Series A, Series B warrants exercisable at $1.49 in $1 million private placement - Bitget
60 Degrees Pharmaceuticals (SXTP) Slips 6.4% as Shares Test Key Support at $1.11Bear Pennant - dars.gov.et
60 Degrees Pharmaceuticals raises $1M in private placement By Investing.com - Investing.com Canada
60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
60 Degrees Pharmaceuticals, Inc. announced that it has received $0.999618 million in funding - marketscreener.com
60 Degrees Pharmaceuticals Announces Minimum Enrollment - GlobeNewswire
60 Degrees Pharmaceuticals hits babesiosis trial enrollment milestone - scanx.trade
60 Degrees Pharmaceuticals Inc (SXTP) Balance Sheet - TradingKey
60 Degrees Pharmaceuticals Inc - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SXTP|60 Degrees Pharmaceuticals Inc|Price:1.140| - TradingKey
60 Degrees Pharmaceuticals Secures US Patent for Tafenoquine Lung Infection Treatment - scanx.trade
60 Degrees Pharmaceuticals Inc (SXTP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
60 Degrees Pharmaceuticals (SXTP) Slips 0.67% as Stock Hovers Near SupportCommon Gap - dars.gov.et
Enterprise value to revenue forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView
60 Degrees Pharmaceuticals Inc (SXTP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
60 Degrees Pharmaceuticals (SCTP) Proxy filing Summary - Quartr
60 Degrees Pharmaceuticals (SCTP) Registration Filing Summary - Quartr
60 Degrees Pharmaceuticals (SXTP) Edges Lower Near Support as Volume Remains SubduedWyckoff Accumulation - dars.gov.et
60 Degrees Pharmaceuticals: FDA-Approved Malaria & Babesiosis Treatments, Clinical Pipeline, and Commercial Growth (2026 Investor Update) – Minichart - Minichart
60 Degrees updates strategy for ARAKODA and profitability - TipRanks
60 Degrees Pharmaceuticals updates investor presentation; outlines Arakoda babesiosis trials, targets profitability - TradingView
Frontier tech research, news & data - MLQ.ai
60 Degrees Pharmaceuticals Inc. (SXTP) Q1 2026 Earnings: EPS Misses Estimates by Wide MarginGuidance Revision Trend - dars.gov.et
SXTP Q1 2026 Earnings: Wider-than-Expected Loss Sends Shares LowerEarnings Season Preview - po-news-eg.net
Enterprise value to EBITDA forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView
60 Degrees Pharmaceuticals, Inc. Warranton 60 Degrees Ph Financial Disclosures & SEC Filings - TradingView
Price to book forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView
60 Degrees Pharmaceuticals (NASDAQ: SXTP) Files 8-K Report Detailing Company Updates and Security Information - Minichart
Price to earnings forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView
Interim Trial Plan Finalized for Tafenoquine Babesiosis Study - TipRanks
60 Degrees Pharmaceuticals readies interim analysis plan for tafenoquine babesiosis trial - TradingView
60 Degrees Pharmaceuticals (SXTP) sets tafenoquine babesiosis interim analysis and sNDA path - Stock Titan
Price to earnings forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView
60 Degrees Pharmaceuticals to Advance Castanospermine for Tick-Borne Diseases Through Florida State University Deal - Moomoo
60 Degrees Pharma gets option to pursue tick-borne disease drug - Stock Titan
60 Degrees Pharma secures option for tick-borne disease IP - scanx.trade
60 Degrees Pharmaceuticals Inc (SXTP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
0.07%
자본화:
|
볼륨(24시간):